4//SEC Filing
Quirk Gerald E 4
Accession 0001209191-22-053571
CIK 0001556263other
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 4:20 PM ET
Size
5.6 KB
Accession
0001209191-22-053571
Insider Transaction Report
Form 4
Quirk Gerald E
Chief Legal Officer
Transactions
- Award
Restricted Stock Units
2022-10-11+45,000→ 45,000 total→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
- [F2]These RSUs will vest as to one half (50%) of the shares on October 11, 2023, and as to one half (50%) of the shares on March 31, 2024.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001479603
Filing Metadata
- Form type
- 4
- Filed
- Oct 12, 8:00 PM ET
- Accepted
- Oct 13, 4:20 PM ET
- Size
- 5.6 KB